GGrantIndex
Sort

53,477 grants matching addiction

Longitudinal pathways between adolescent social media use and substance use: Informing evidence-based guidance

$703,457
Jason M Nagata · University Of California, San Francisco · R01 · FY2025 · DA

Linking Russian Narcology & HIV Care to Enhance Treatment, Retention, & Outcomes

$703,320
Jeffrey H Samet · Boston Medical Center · R01 · FY2011 · DA

Integrating Epigenomics in Human Brain and Genomics of Nicotine Dependence

$703,285
Dana B Hancock · Research Triangle Institute · R01 · FY2018 · DA

Graduate Training in Neuroscience

$703,131
Joshua I Gold · University Of Pennsylvania · T32 · FY2018 · NS

Translational Studies of Prefrontal Control of Fear Extinction

$703,123
Gregory J. Quirk · University Of Puerto Rico Med Sciences · R01 · FY2009 · MH

Evaluation of Dialectical Behavior Therapy (DBT)

$703,115
Marsha Marie Linehan · University Of Washington · R01 · FY2006 · DA

Brain changes and outcomes accompanying evidence-based treatment in high-risk youth

$703,046
Kent A Kiehl · The Mind Research Network · R01 · FY2015 · HD

Discovery of Bifunctional NOP/Opioid Receptor Ligands for Drug Abuse Therapy

$703,039
Nurulain T Zaveri · Astraea Therapeutics, Llc · R01 · FY2013 · DA

Developing an FDA-Qualified Clinical Outcomes Assessment for Opioid Withdrawal

$702,974
Laura Brandt · City College Of New York · UG3 · FY2025 · DA

Pilot Project Program

$702,958
Robert A Koza · Mainehealth · U54 · FY2025 · GM

Center to Improve System Performance of Substance Use Disorder Treatment

$702,873
Constance M Horgan · Brandeis University · P30 · FY2019 · DA

Targeting Nrf2 for Cancer Chemoprevention

$702,815
Thomas W Kensler · University Of Pittsburgh At Pittsburgh · R35 · FY2015 · CA

Methamphetamine Abuse, Inhibitory Control: Implications for Treatment

$702,751
Edythe D London · University Of California Los Angeles · P20 · FY2007 · DA

NEUROPSYCHOPHARMACOLOGY: MULTIDISCIPLINARY TRAINING

$702,744
Marisa Roberto · Scripps Research Institute, The · T32 · FY2022 · AA

MODELING THE POLICY IMPACT OF CIGARETTE AND SMOKELESS USE ON US MORTALITY

$702,719
David T Levy · Georgetown University · R01 · FY2014 · DA

Adolescent striatal neurophysiological maturation underlying the transition to adult stabilization of behavior

$702,604
Beatriz Luna · University Of Pittsburgh At Pittsburgh · R37 · FY2024 · MH

Single-cell multi-omic analysis of opioid-mediated HIV disease pathogenesis

$702,514
Kathleen L Collins · University Of Michigan At Ann Arbor · R33 · FY2025 · DA

Neurotensin receptor 1 as a novel target for opioid use disorder and discovery of new small molecule probes

$702,476
Lauren M Slosky · University Of Minnesota · R01 · FY2025 · DA

Effects of Prenatal Opiates on Infant Brain and Neurobehavioral Development

$702,420
Karen M Grewen · Univ Of North Carolina Chapel Hill · R01 · FY2019 · DA

An Experimental Medicine Approach for the Mechanistic Understanding of Cocaine Use Disorder: Reinforcer Pathology

$702,411
Stephen M Laconte · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · DA

Morphine and the Neuropathogenesis of SIV in Macaques

$702,275
Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2009 · DA

Western States Node of the National Drug Abuse Treatment Clinical Trials Network

$702,234
James L. Sorensen · University Of California, San Francisco · UG1 · FY2017 · DA

Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco products

$702,233
Mark G Lesage · Hennepin Healthcare Research Institute · R01 · FY2021 · DA

The National Drug Abuse Treatment Clinical Trials Network

$702,119
Roger D. Weiss · Mclean Hospital · UG1 · FY2016 · DA

Dynamic epigenomic landscape of opioid abuse following early-life adversity

$702,093
Stephen Vincent Mahler · University Of California-Irvine · U01 · FY2023 · DA